SENIOR TRI INVESTIGATORS AND ADMINISTRATORS
- Senior Staff (McLellan, Weinstein, Metzger)
- Section on Behavioral Treatments and Applications
- Section on Law & Ethics
- Center on the Continuum of Care: Monitoring and Adapting Addictions Treatment
- Center for Policy Research and Analysis
- Parents Translational Research Center
- Section on Adolescents
- Treatment Research Solutions Group
- Clinical Trials Network
Ken
Winters, Ph.D.
is the director of the Center for Adolescent Substance Abuse Research,
a Professor in the Department of Psychiatry at the University of Minnesota,
and a Senior Scientist with the Treatment Research Institute, Philadelphia,
PA. He received his B.A. from the University of Minnesota and a Ph.D.
in psychology (Clinical) from the State University of New York at Stony
Brook. His primary research interests are the assessment and treatment
of adolescent drug abuse. Dr. Winters has published numerous research
articles in this area, and has received several research grants from the
National Institute of Health (NIH) and various foundations. He currently
directs grants funded by NIH to study the effectiveness of brief interventions
with drug abusing adolescents. He is on the editorial boards of the Journal
of Child and Adolescent Substance Abuse and the Journal of Substance
Abuse Treatment, and he was also the lead editor for two Treatment
Improvement Protocol Series published by the Center for Substance
Abuse Treatment (SAMHSA) that focused on adolescent drug abuse assessment
and treatment. Dr. Winters is a consultant to many organizations, including
the Hazelden Foundation, National Institute on Drug Abuse, Center for
Substance Abuse Treatment, the Partnership for Drug-Free America, World
Health Organization, and the Mentor Foundation (an international drug
abuse prevention organization).
Amelia
M. Arria, Ph.D., Senior Scientist, is an adolescent and young-adult
specialist at TRI and Principal Investigator on the College Life Study
at the School of Public Health, University of Maryland, College Park.
Her primary area of interest is the identification of risk factors for
adolescent and young adult drug involvement. She is also involved in research
evaluating the safety and efficacy of buprenorphine and methadone for
pregnant opioid-dependent women, prenatal methamphetamine exposure, and
characterizing faith-based elements of drug treatment.
Övgü Kaynak, Ph.D. is an Associate Research Scientist at TRI and Data Analyst and Scientific Writer for the Center. Dr. Kaynak has extensive research experience related to psychosocial risk factors associated with negative outcomes (i.e. drug use and aggression) in children and adolescents. She is particularly interested in the combined effects of social and individual risk factors on drug use. She holds a Bachelor of Arts degree in Psychology from Pennsylvania State University, a Master of Science of Education in Interdisciplinary Studies in Human Development from the University of Pennsylvania, and a Doctorate degree in Public Health with a concentration in Social and Behavioral Health from Temple University. For the Parents Center, Dr. Kaynak analyzes data and prepares manuscripts that focus on parenting and adolescent substance use problems. Findings from published manuscripts are then translated into tools that parents can use when addressing the substance use problems of their adolescents.
Behavioral
Treatments and Applications
Law
& Ethics
Center
on the Continuum of Care:
Monitoring
and Adapting Addiction Treatment
Center
for Policy Research and
Analysis
Parents Translational Research Center
Adolescents
Treatment
Research Solutions
Clinical
Trials Network
Projects-at-a-Glance
TRI Collaborators
Addiction
Severity Index (ASI)
Other
Assessment Instruments
Publications
Presentations
Archives
Training
Order
TRI Resources
Career
Opportunities
Contact
Us
Research
Briefs
Sign
up for E-Alerts